Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives

dc.contributor.author Evranos-Aksoz, Begüm
dc.contributor.author Yelekçi, Kemal
dc.contributor.author Baysal, İpek
dc.contributor.author Yabanoğlu-Çiftçi, Samiye
dc.contributor.author Djikic, Teodora
dc.contributor.author Yelekçi, Kemal
dc.contributor.author Uçar, Gülberk
dc.contributor.author Ertan, Rahmiye
dc.contributor.other Molecular Biology and Genetics
dc.date.accessioned 2019-06-27T08:02:11Z
dc.date.available 2019-06-27T08:02:11Z
dc.date.issued 2015
dc.department Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü en_US
dc.description.abstract A group of 35-diaryl-2-pyrazoline and hydrazone derivatives was prepared via the reaction of various chalcones with hydrazide compounds in ethanol. Twenty original compounds were synthesized. Ten of these original compounds have a pyrazoline structure nine of these original compounds have a hydrazone structure and one of these original compounds has a chalcone structure. Structural elucidation of the compounds was performed by IR H-1 NMR C-13 NMR mass spectral data and elemental analyses. These compounds were tested for their inhibitory activities toward the A and B isoforms of human monoamine oxidase (MAO). Except for 3k and 6c all compounds were found to be competitive reversible and selective inhibitors for either one of the isoforms (hMAO-A or MAO-B). Compounds 3k and 6c were found to be competitive reversible but non-selective MAO inhibitors. Compound 6h showed hMAO-B inhibitory activity whereas the others potently inhibited hMAO-A. Compound 5c showed higher selectivity than the standard drug moclobemide. According to the experimental K-i values compounds 6i 6d and 6a exhibited the highest inhibitory activity toward hMAO-A. The AutoDock 4.2 program was employed to perform automated molecular docking. The calculated results obtained computationally were in good agreement with the experimental values. en_US]
dc.identifier.citationcount 20
dc.identifier.doi 10.1002/ardp.201500212 en_US
dc.identifier.endpage 756
dc.identifier.issn 0365-6233 en_US
dc.identifier.issn 1521-4184 en_US
dc.identifier.issn 0365-6233
dc.identifier.issn 1521-4184
dc.identifier.issue 10
dc.identifier.pmid 26293971 en_US
dc.identifier.scopus 2-s2.0-84942987491 en_US
dc.identifier.scopusquality Q2
dc.identifier.startpage 743 en_US
dc.identifier.uri https://hdl.handle.net/20.500.12469/569
dc.identifier.uri https://doi.org/10.1002/ardp.201500212
dc.identifier.volume 348 en_US
dc.identifier.wos WOS:000362565600006 en_US
dc.institutionauthor Yelekçi, Kemal en_US
dc.language.iso en en_US
dc.publisher Wiley-VCH Verlag GmbH en_US
dc.relation.journal Archiv Der Pharmazie en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.scopus.citedbyCount 27
dc.subject 2-Pyrazoline en_US
dc.subject Hydrazone en_US
dc.subject MAO inhibitors en_US
dc.subject Molecular docking en_US
dc.title Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives en_US
dc.type Article en_US
dc.wos.citedbyCount 21
dspace.entity.type Publication
relation.isAuthorOfPublication 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isAuthorOfPublication.latestForDiscovery 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isOrgUnitOfPublication 71ce8622-7449-4a6a-8fad-44d881416546
relation.isOrgUnitOfPublication.latestForDiscovery 71ce8622-7449-4a6a-8fad-44d881416546

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Synthesis and Screening of Human Monoamine Oxidase-AInhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format
Description: